Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis.
about
Pediatric Pulmonology year in review 2015: Part 4.Clinical utility of C-reactive protein to predict treatment response during cystic fibrosis pulmonary exacerbationsEffect of enterovirus D68 on Lung Clearance Index in patients with cystic fibrosis: A case reportStandardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations.Characterization of Inpatient Cystic Fibrosis Pulmonary Exacerbations.Cystic fibrosis year in review 2016.Probability of IV antibiotic retreatment within thirty days is associated with duration and location of IV antibiotic treatment for pulmonary exacerbation in cystic fibrosis.The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry.Weight gain during acute treatment of an initial pulmonary exacerbation is associated with a longer interval to the next exacerbation in adults with cystic fibrosis.Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial.Optimising treatment of CF pulmonary exacerbation: a tough nut to crackAntibiotic duration and changes in FEV1 are not associated with time until next exacerbation in adult cystic fibrosis: a single center study.Study design considerations for the Standardized Treatment of Pulmonary Exacerbations 2 (STOP2): A trial to compare intravenous antibiotic treatment durations in CF.Poor recovery from cystic fibrosis pulmonary exacerbations is associated with poor long-term outcomes.Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations.
P2860
Q30250335-946CEEF2-CEED-4127-AEE3-A234BC6B57CBQ36274154-2EB275FA-2B03-4A7F-8FFD-53DB24CC28E3Q36379100-5F8FA0EA-70EB-44B7-8B16-593BB0AE01B8Q38688865-8E33687D-4830-40C6-A781-194CB3ED850EQ38765336-79D9D1F5-DF44-4BB5-8010-77EC76A51BB2Q39368904-F50F5F14-E584-448C-B140-144A522E6A12Q39800405-76F78AC6-1353-4E11-9E8A-305F9EA5E14FQ39851104-2F415B9E-AC2C-4BB6-BFC9-041D4AFC4E84Q40065639-9C5529E5-EDBF-462C-AE56-1340934C1D6BQ40449041-4CAD0CB1-03A3-4046-8CB7-C9E81AC5F384Q42336550-73E09D07-4B38-401A-BB70-8089B073E8ECQ47107604-A6D05084-5488-4F3E-BA3C-D8CCF6B9C256Q47422154-3A8B6C7C-7D23-4829-AD6B-E7388D5F8DC6Q48021227-401CBE18-6D82-429B-8FB0-C5C093B2568DQ55437809-BAF1D55D-B1CC-40C7-A682-235C8851FB12
P2860
Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis.
@ast
Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis.
@en
type
label
Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis.
@ast
Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis.
@en
prefLabel
Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis.
@ast
Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis.
@en
P2093
P2860
P1433
P1476
Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis
@en
P2093
Bruce C Marshall
Don B Sanders
Patrick A Flume
Scott D Sagel
Valeria Thompson
P2860
P304
P356
10.1136/THORAXJNL-2014-206750
P407
P577
2015-04-24T00:00:00Z